# Association Between Dysmenorrhea and Endometrial Cancer: A Mendelian Randomization Study

**Authors:** Qiuyuan Huang, Xizhen Huang, Liyuan Huang, Yanglin Wang, Suyu Li, Xiangqin Zheng

PMC · DOI: 10.1155/prm/4194108 · Pain Research & Management · 2025-07-23

## TL;DR

This study suggests that dysmenorrhea may be linked to a lower risk of endometrial cancer, offering new insights into reproductive health.

## Contribution

The study provides novel causal evidence using Mendelian randomization to explore the relationship between dysmenorrhea and endometrial cancer.

## Key findings

- Dysmenorrhea was significantly inversely associated with endometrial cancer risk.
- The protective association remained significant after adjusting for confounders.
- Other dysmenorrhea-related factors showed no significant link to endometrial cancer.

## Abstract

Background: Dysmenorrhea is a common gynecological symptom among reproductive-aged women, associated with substantial pain and decreased quality of life. Previous studies have suggested that inflammatory and hormonal fluctuations linked to dysmenorrhea may influence endometrial cancer (EC) risk though causality remains uncertain. This study aimed to investigate potential causal relationships between dysmenorrhea (including pain severity, analgesic use, endometriosis, and related pelvic pain) and EC risk using a Mendelian randomization (MR) approach.

Methods: A two-sample MR analysis was conducted using genome-wide association study (GWAS) data, selecting single nucleotide polymorphisms (SNPs) significantly associated with dysmenorrhea to assess EC risk. Primary analysis was performed with the inverse-variance weighted (IVW) method, while weighted median and MR-Egger analyses were conducted to enhance robustness.

Results: The IVW analysis showed a significant inverse association between dysmenorrhea and EC risk (OR = 0.883; 95% CI: 0.794–0.983; and p=0.023), which remained significant after adjusting for confounders (OR = 0.868; 95% CI: 0.775–0.971; and p=0.0136). Sensitivity analyses supported this protective association. Other factors, including pain severity, analgesic use, endometriosis, and related pelvic pain, showed no significant association with EC.

Conclusion: This study indicates a potential inverse relationship between dysmenorrhea and EC risk. These findings provide novel causal evidence for understanding complex associations in female reproductive health, underscoring the need for further research on dysmenorrhea in EC prevention.

## Linked entities

- **Diseases:** dysmenorrhea (MONDO:1060205), endometrial cancer (MONDO:0002447), endometriosis (MONDO:0005133)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** carcinogenic (MESH:D011230), ovarian cancer (MESH:D010051), hypertension (MESH:D006973), abdominal pain (MESH:D015746), obesity (MESH:D009765), pelvic pain (MESH:D017699), Dysmenorrhea (MESH:D004412), diabetes (MESH:D003920), EC (MESH:D016889), tumorigenesis (MESH:D063646), chronic (MESH:D002908), Dysmenorrheic pain (MESH:D010146), Endometriosis (MESH:D004715), inflammation (MESH:D007249), cancer (MESH:D009369), disorders of the female reproductive system (MESH:D060737)
- **Chemicals:** progesterone (MESH:D011374), prostaglandin (MESH:D011453)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs4687086, rs10989462, rs12543117, rs3174744, rs142412095, rs3094610, rs61768001, rs4876346, rs7775980, rs7766106, rs11031005, rs10808874

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12310317/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12310317/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12310317/full.md

---
Source: https://tomesphere.com/paper/PMC12310317